Bayer Articles
Bayer names Martin Dawkins as MD for UK and Ireland
17 July 2006
Bayer completes Schering AG takeover
17 July 2006
EFPIA re-elects president and names new VPs
10 July 2006
Bayer buys more shares in Schering AG
10 July 2006
Stock Commentary - Europe - week to July 3, 2006
10 July 2006
J&J wins bidding war for Pfizer
3 July 2006
Part D effect on US drug prices: up or down?
3 July 2006
Way clear for Bayer bid for Schering AG
26 June 2006
Stock Commentary - Europe - week to June 12, 2006
19 June 2006
Pfizer licenses Bayer's DGAT-1 inhibitors
19 June 2006
Merck KGaA moves to scupper Schering/Bayer marriage?
19 June 2006
Merck KGaA confirms 5%+ stake in Schering AG
12 June 2006
Bayer extends Schering AG takeover period
5 June 2006
Shionogi's 2005 sales 196.4B yen, down 1.5%
29 May 2006
Strong PKC profile for BAY 79-4980
29 May 2006
EC OKs Bayer's buy of Schering AG
29 May 2006
Nexium reduces aspirin's GI complications
29 May 2006
Bayer grants $2.75M to hemophilia research
29 May 2006
Bayer welcomes strong data on Avelox in ABS
29 May 2006
Bayer's cPSA test fares well against tPSA
22 May 2006
Seatle Genetics recruits Pamela Trail as CSO
22 May 2006
Stock Commentary - Europe - week to May 8, 2006
15 May 2006
Enrollment complete in two Ph III Nexavar trials
15 May 2006
Altana in talks to sell pharma unit
8 May 2006
Bayer AG sees record-breaking 1st qtr with EBIT up 8.2% to $1.56 billion on strong health care sales
8 May 2006
CHMP thumbs-up for Bayer's Nexavar
8 May 2006
India struggles with conflicting brand names
8 May 2006
Record growth for Boeh Ing Japan
1 May 2006
Bayer Yakuhin sees 2005 sales rise 4%
1 May 2006
Bayer/Schering AG deal satisfied HSR Act
1 May 2006
Schering AG names Detlef Olufs to supervisory board
24 April 2006
Onyx/Bayer's Nexavar gains EC Orphan Status
24 April 2006
16% 1st-qtr 2006 sales rise for Schering AG
24 April 2006
Stock Commentary - Europe - week to April 10, 2006
17 April 2006
Headlines 25 years ago this week....
17 April 2006
S-P announces positive Avelox study data
17 April 2006
Stock Commentary - Europe - week to April 3, 2006
10 April 2006
Bayer's Levitra improves erections 81%
10 April 2006
Japan to discuss pediatric drug use
10 April 2006
Impact of Bayer's buy of Schering AG
3 April 2006
Bayer/Onyx' Nexavar cleared by Swissmedic
3 April 2006
Sweden's drug authority starts ProQuin review
3 April 2006
Stock Commentary - Europe - week to March 27, 2006
3 April 2006
Bayer "will not break up Schering AG"
3 April 2006
Bayer acquires OriGene's TrueClone cDNAs
20 March 2006
Bayer chief slams German health policy
20 March 2006
Stock Commentary - Europe - week to Mar 6, 2006
13 March 2006
Bayer's income reaches 1.59B in 2005, up 133%
13 March 2006
Bark extract reduces osteoarthritic pain
27 February 2006
Bayer to take part in NanoCare project
27 February 2006
Bayer/Onyx launch Ph III Nexavar trial
27 February 2006
Cinnamon can lower blood sugar levels
20 February 2006
Pfizer elaborates on consumer products divestiture
20 February 2006
Stock Commentary - Europe - week to Feb 13, 2006
20 February 2006
FDA issues "advisory" on Bayer's Trasylol
20 February 2006
Pfizer considers selling consumer unit
13 February 2006
Stock Commentary - Europe - week to feb 6
13 February 2006
Stock Commentary - Europe - week to Jan 30
6 February 2006
Pharma/biotech mergers and acquisitions during 2005
6 February 2006
S-Ps Avelox outperforms Levaquin in CAP study
6 February 2006
NEJM study finds health risks associated with Bayer's Trasylol
30 January 2006
Stock Commentary - Europe - week to Jan 23
30 January 2006
Bayer releases Kognate reconstitution system
30 January 2006
CDC welcomes growth of aspirin consumption
30 January 2006
Bayer to pay up to $385M for ex-US sale rights to Nuvelo's Ph III thrombolytic, alfimeprase
16 January 2006
Stock Commentary - Europe - week to Jan 9
16 January 2006
SPECTRUM week to Jan 9
16 January 2006
First Horizon sees growing partnership with Bayer
16 January 2006
Rhodia to sell drug synthesis unit to Shasun
16 January 2006
Bayer and J&J honored in US Presidential award
16 January 2006
Bayer Healthcare to market telmisartan in Europe
9 January 2006
Stock Commentary - Europe - week to Jan 9
9 January 2006
Update: Bayer gets first, US, approval for Nexavar
9 January 2006
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
